Hypermethylation of microRNA‐149 activates SDF‐1/CXCR4 to promote osteogenic differentiation of mesenchymal stem cells

Abstract

MicroRNAs (miRs) involve in osteogenic differentiation and osteogenic potential of mesenchymal stem cells (MSCs). Accordingly, the present study aimed to further uncover role miR‐149 plays in osteogenic differentiation of MSCs with the involvement of the stromal cell‐derived factor‐1 (SDF‐1)/CXC chemokine receptor‐4 (CXCR4) pathway. Initially, the osteogenic differentiation model was induced. Next, the positive expression of STRO‐1 in periosteum, alkaline phosphatase (ALP) activity, osteocalcin (OCN) protein content, and the calcium deposition in MSCs were determined. MSCs were treated with DNA methyltransferase inhibitor 5‐aza‐CdR, SDF‐1 neutralizing antibody, or CXCR4 antagonist AMD3100 to investigate their roles in osteogenic differentiation; with the expression of CD44, CD90, CD14, and CD45 detected. Furthermore, the levels of SDF‐1 and CXCR4, and the genes related to stemness (Nanog, Oct‐4, and Sox‐2) were measured to explore the effects of miR‐149. The obtained data revealed the upregulation of STRO‐1 in the periosteum. miR‐149 could specifically bind to SDF‐1. Besides, increased miR‐149 methylation, higher ALP activity and OCN content, decreased positive rates of CD44 and CD90, and increased positive rates of CD14 and CD45 were found in osteogenic differentiation of MSCs. Subsequently, 5‐Aza‐CdR treatment reversed the above‐mentioned effects. MSCs were finally treated with SDF‐1 neutralizing antibody or AMD3100 to decrease Nanog, Oct‐4, and Sox‐2 expression. Taken together these results, miR‐149 hypermethylation has the potential to activate the SDF‐1/CXCR4 pathway and further promote osteogenic differentiation of MSCs.